Patent intelligence · US
US 12304901
Selective ligands for tau aggregates
Selective ligands for tau aggregates
Patent details — US 12304901
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 20, 2025
- Expiration
- May 15, 2045
- Applicant
- Sentonix, Inc.
- Claims
- 18
- CPC classes
- A61K, A61K31/4545, A61K51/0455, A61P
Quick answer
US 12304901 (Selective ligands for tau aggregates) is held by Sentonix, Inc.. Status: granted. Granted May 20, 2025. Expires May 15, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Sentonix, Inc.
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K31/4545, A61K51/0455, A61P, A61P25/28
More from Sentonix, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12383733
Iontophoresis-based patch type medicine absorption device
granted -
US 12365879
Synthetic chimeric poxviruses
granted -
US 12156897
Magnesium-containing oxytocin formulations and methods of use
granted -
US 12156864
Analogs of cyclobenzaprine and amitryptilene
granted -
US 12097183
Pharmaceutical composition for treating migraine
granted -
US 12090139
Formulations comprising triptan compounds
granted -
US 11998516
Methods and compositions for treating depression using cyclobenzaprine
granted
Frequently asked questions
What is US patent 12304901?
US 12304901 (Selective ligands for tau aggregates) is held by Sentonix, Inc.. Status: granted. Granted May 20, 2025. Expires May 15, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12304901?
Sentonix, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 86 pharmaceutical patents for this assignee.
When does US 12304901 expire?
Our index shows an expiration date of May 15, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.